Shape Therapeutics
Shape Therapeutics develops programmable RNA medicines that use AI and RNA technology to address genetic causes of disease. Its work includes RNA editing, next-generation AAV delivery and gene therapy manufacturing for pharmaceutical innovators developing treatments for rare genetic disorders and other diseases.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2018
- Type
- Corporation Seattle business license
- Employees
- 51–200
- Registered name
- Shape Therapeutics Inc Seattle business license
- Stage
- Series B
Is this your organization? Claim it
Members see Shape Therapeutics's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
David Huss Executive, Chief Scientific Officer and Interim CEO
-
Francois Vigneault Former founder